Get started
NEUROTECH INTERNATIONAL LIMITEDNEUROTECH INTERNATIONAL LIMITEDNEUROTECH INTERNATIONAL LIMITED

NEUROTECH INTERNATIONAL LIMITED

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

NTI chart


Full chart

NTI upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪33.59 M‬ AUD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.012 AUD
Net income (FY)
‪−5.07 M‬ AUD
Revenue (FY)
‪1.96 K‬ AUD
Shares float
‪925.42 M‬
Beta (1Y)
1.90

About NEUROTECH INTERNATIONAL LIMITED


Sector
Health Technology
Industry
Medical Specialties
CEO
Anthony Filippis
Website
neurotechinternational.com
Headquarters
Nedlands
Founded
2016
ISIN
AU000000NTI9
FIGI
BBG00DSXRN99
Neurotech International Ltd. engages in the research, design, development, and manufacture of medical devices and solutions in Australia. Its product includes Mente Autism for the diagnosis and treatment of autism. The company was founded on January 15, 2016 and is headquartered in Nedlands, Australia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

NTI news



Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as NTI.

Frequently Asked Questions


The current price of NTI is 0.034 AUD — it has increased by 6.25% in the past 24 hours. Watch NEUROTECH INTERNATIONAL LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange NEUROTECH INTERNATIONAL LIMITED stocks are traded under the ticker NTI.
NTI stock has risen by 21.43% compared to the previous week, the month change is a 17.24% rise, over the last year NEUROTECH INTERNATIONAL LIMITED has showed a −69.09% decrease.
NTI reached its all-time high on Nov 25, 2016 with the price of 0.486 AUD, and its all-time low was 0.003 AUD and was reached on Mar 27, 2020. View more price dynamics on NTI chart.
See other stocks reaching their highest and lowest prices.
NTI stock is 5.88% volatile and has beta coefficient of 1.90. Track NEUROTECH INTERNATIONAL LIMITED stock price on the chart and check out the list of the most volatile stocks — is NEUROTECH INTERNATIONAL LIMITED there?
Today NEUROTECH INTERNATIONAL LIMITED has the market capitalization of ‪33.59 M‬, it has decreased by −14.54% over the last week.
Yes, you can track NEUROTECH INTERNATIONAL LIMITED financials in yearly and quarterly reports right on TradingView.
NEUROTECH INTERNATIONAL LIMITED is going to release the next earnings report on Aug 27, 2025. Keep track of upcoming events with our Earnings Calendar.
NTI earnings for the last half-year are −0.73 AUD per share, whereas the estimation was −0.01 AUD, resulting in a ‪−14.50 K‬% surprise. The estimated earnings for the next half-year are −0.01 AUD per share. See more details about NEUROTECH INTERNATIONAL LIMITED earnings.
NEUROTECH INTERNATIONAL LIMITED revenue for the last half-year amounts to 232.00 AUD, despite the estimated figure of ‪2.40 M‬ AUD. In the next half-year revenue is expected to reach ‪100.00 K‬ AUD.
NTI net income for the last half-year is ‪−7.44 M‬ AUD, while the previous report showed ‪−4.34 M‬ AUD of net income which accounts for −71.52% change. Track more NEUROTECH INTERNATIONAL LIMITED financial stats to get the full picture.
No, NTI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NEUROTECH INTERNATIONAL LIMITED EBITDA is ‪−12.39 M‬ AUD, and current EBITDA margin is ‪−446.26 K‬%. See more stats in NEUROTECH INTERNATIONAL LIMITED financial statements.
Like other stocks, NTI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NEUROTECH INTERNATIONAL LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NEUROTECH INTERNATIONAL LIMITED technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NEUROTECH INTERNATIONAL LIMITED stock shows the sell signal. See more of NEUROTECH INTERNATIONAL LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.